These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7871656)

  • 1. [Role of local factors in the pathogenesis of diabetic retinopathy].
    Nesterov AP
    Vestn Oftalmol; 1994; 110(4):7-9. PubMed ID: 7871656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenesis and treatment of diabetic retinopathy (author's transl)].
    Freyler H
    Klin Monbl Augenheilkd; 1976 May; 168(05):661-72. PubMed ID: 957562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Occurrence of changes in the eye in diabetic retinopathy with significant myopia].
    Dujić M; Misailović K; Nikolić Lj; Ignjacev M
    Srp Arh Celok Lek; 1998; 126(11-12):457-60. PubMed ID: 9921019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of insulin-like growth factor I in the development of diabetic retinopathy].
    Gacka M; Adamiec J
    Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structural and functional disorders of transcapillary metabolism if retina in patients with diabetic retinopathy].
    Sorokin EL; Smoliakova GP
    Vestn Oftalmol; 1997; 113(2):16-9. PubMed ID: 9229896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
    Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J; Oficjalska-Młyńczak J
    Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral diabetic macular oedema secondary to central retinal vein congestion.
    Christoffersen N; Larsen M
    Acta Ophthalmol Scand; 2004 Oct; 82(5):591-5. PubMed ID: 15453859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.
    Kanwar M; Chan PS; Kern TS; Kowluru RA
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3805-11. PubMed ID: 17652755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial F-actin cytoskeleton in the retinal vasculature of normal and diabetic rats.
    Yu PK; Yu DY; Cringle SJ; Su EN
    Curr Eye Res; 2005 Apr; 30(4):279-90. PubMed ID: 16020258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic Acid.
    Berkowitz BA; Roberts R; Stemmler A; Luan H; Gradianu M
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4753-8. PubMed ID: 17898301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
    Gardiner TA; Anderson HR; Stitt AW
    J Pathol; 2003 Oct; 201(2):328-33. PubMed ID: 14517851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Para-inflammation in the aging retina.
    Xu H; Chen M; Forrester JV
    Prog Retin Eye Res; 2009 Sep; 28(5):348-68. PubMed ID: 19560552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could diabetic retinopathy be an autoimmune disease?
    Kastelan S; Zjacić-Rotkvić V; Kastelan Z
    Med Hypotheses; 2007; 68(5):1016-8. PubMed ID: 17125935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.
    Limb GA; Hickman-Casey J; Hollifield RD; Chignell AH
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2453-7. PubMed ID: 10476819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of the osmotic pressure of the blood in the pathogenesis of diabetic changes in the retina].
    Zapuskalov IV; Filippova SV; Shilova OG; Krivosheina OI
    Vestn Oftalmol; 2000; 116(2):32-4. PubMed ID: 11055223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.